VCEL FY 2025 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$276M+16.5% YoY

Gross Profit

$206M74.4% margin

Operating Income

$11M4.0% margin

Net Income

$17M6.0% margin

EPS (Diluted)

$0.32

Cash Flow

Operating Cash Flow

$52M

Free Cash Flow

$25M

Stock-Based Comp.

$39M

Balance Sheet

Total Assets

$488M

Total Liabilities

$133M

Stockholders' Equity

$355M

Cash & Equivalents

$100M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$276M	$237M	+16.5%
Gross Profit	$206M	$172M	+19.5%
Operating Income	$11M	$5M	+144.4%
Net Income	$17M	$10M	+59.4%